Health Care/Hospital
Simulare Medical Launches the Alveolar Bone Graft Simulator
ABG Simulator New Addition to Further Support Cleft Reconstructive Surgical Training TAIPEI, Nov. 8, 2023 /PRNewswire/ -- Simulare Medical, a division of Smile Train Inc. (New York) announces the launch of the Alveolar Bone Graft (ABG) simulator, the latest high-fidelity surgical item in its gro...
2023-11-08 10:00
1909
Docquity Expands Digitized Patient Access Programs To Enhance Healthcare Outcomes in Thailand
* After a successful pilot in the Philippines, five DocquityCare Patient Access Programs (PAPs)have been launched in Thailand * DocquityCare PAP will support more than 100 hospitals and 250 healthcare professionals (HCPs) to improve patient care for those with cancer and other life-threatenin...
2023-11-08 10:00
1715
WuXi Biologics Receives AAA MSCI ESG Rating
SHANGHAI, Nov. 7, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced it has received an AAA rating from Morgan Stanley Capital International (MSCI) ESG Ratings, the highest rating for compan...
2023-11-08 08:30
1298
Antengene to Host 2023 R&D Day and Discuss Key Data with KOLs
* During the event, Antengene will review promising data of its R&D pipeline, includingATG-031 (anti-CD24 monoclonal antibody), ATG-101 (PD-L1/4-1BB bispecific antibody), ATG-022 (Claudin 18.2 antibody-drug conjugate), ATG-037 (CD73 inhibitor), and ATG-008 (dual mTORC1/2 inhibitor). * The vir...
2023-11-08 08:30
1594
Flagship Pioneering Expands into Asia-Pacific Region, with Regional Hub in Singapore
André Andonian Joins Flagship to Lead APAC Region SINGAPORE, Nov. 8, 2023 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced its expansion into theAsia-Pacific region, with the opening of a regional hub inSingapore. This follows the company's expansion into ...
2023-11-08 06:00
1587
Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer
* ORSERDU is the first treatment specifically approved for patients with ER+, HER2- advanced or metastatic breast cancer tumors that harbor ESR1 mutations, representing the first innovation in endocrine therapy in nearly 20 years. * ESR1 mutations are present in up to 40% of ER+, HER2- advance...
2023-11-08 02:01
1478
Rootique DUO launches on Indiegogo, revolutionizing hair loss treatment with a 15s mess-free process
HONG KONG, Nov. 7, 2023 /PRNewswire/ -- Rootique, a startup that leverages technology to optimize the performance of hair loss solutions, announced today the launch of its pioneering product Rootique DUO, designed to simplify the application of topical hair loss treatments to boost the chance of ...
2023-11-08 00:00
1241
Discovery Life Sciences Announces New CEO
Greg Herrema to Spearhead Next Phase of Global Biospecimen and Biomarker Company's Expansion HUNTSVILLE, Ala., Nov. 7, 2023 /PRNewswire/ -- Discovery Life Sciences, the Biospecimen and Biomarker Specialists, announced today the appointment ofGreg Herrema as its new chief executive officer. A lea...
2023-11-07 23:01
1659
MAJOR FITNESS opens pre-orders on its less space, more exercises foldable power rack, the Lightning F35
ATLANTA, Ga., Nov. 7, 2023 /PRNewswire/ -- Optimizing gym equipment so people
can train at home on a budget, even ifthey live in an apartment with limited
space, is in reach more than ever now with the launch of the newall-in-one
Lightning F35 from MAJOR FITNESS.
2023-11-07 22:00
1391
Nuevocor presents pre-clinical data at ESGCT and AHA meetings
SINGAPORE, Nov. 7, 2023 /PRNewswire/ -- Nuevocor, a pre-clinical stage biotechnologycompany focused on developing cardiac genetic medicines through a unique platform to understand the mechanobiological causes of disease, announced today a pair of presentations at two major meetings, the European ...
2023-11-07 22:00
1447
Recruitment target achieved for Phase II SAR-Bombesin prostate cancer trial
SYDNEY, Nov. 7, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce that 50 patients have no...
2023-11-07 21:58
1066
Turn Biotechnologies First to Deliver mRNA into the Dermis Using Proprietary LNPs, With No Distribution to Other Organs
* Company's eTurna™ delivery platform ensures unprecedented precision, safety * In-vivo biodistribution of mRNA into dermal cells, tissues shows high transfection efficiency, gene expression * Data presented at ASDS Annual Meeting MOUNTAIN VIEW, Calif., Nov. 7, 2023 /PRNewswire/ -- Turn Biot...
2023-11-07 21:30
2294
Kexing Biopharm Attended CPHI Worldwide 2023
SHENZHEN, China, Nov. 7, 2023 /PRNewswire/ -- Recently, CPHI Worldwide 2023 was successfully held inBarcelona, Spain. Kexing Biopharm exhibited more than ten kinds of high-quality medical products in the fields of tumor, autoimmune, anti-virus, etc., including Infliximab, Adalimumab, Bevacizumab,...
2023-11-07 20:09
1219
Akeso's Cadonilimab (PD-1/CTLA-4) Phase III Trial Meets Primary Endpoint at Interim Analysis Demonstrating Strong Overall Survival Benefit as First-line Treatment in All-comer Patients with Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC)
HONG KONG, Nov. 7, 2023 /PRNewswire/ -- Akeso (9926.HK) announced positive results from an interim analysis of AK104-302 study, a randomized, double-blind, multicenter, phase III clinical study evaluating PD-1/CTLA-4 bispecific antibody, cadonilimab (开坦尼®) in combination with capecitabine plus...
2023-11-07 20:00
1704
Registration for the 7th IFPA Conference 2024 now open
STOCKHOLM, Nov. 7, 2023 /PRNewswire/ -- IFPA (International Federation of Psoriasis Associations) is thrilled to announce the 7th IFPA Conference (former World Psoriasis & Psoriatic Arthritis Conference), set to take place fromJune 27 to 29, 2024, in the vibrant city of Stockholm, Sweden. Establi...
2023-11-07 18:00
1528
First Mover of Global Trade Index Based On Biome Molecule, Kwanyoung Park of AndKwan Natural Science
* Creating world-class innovation by redefining how international standards are established with eco-friendly bio materials and a system. * Patent registration for one-stop system from procurement of raw materials and golden time orders from all over the world to search for optimal routes for ...
2023-11-07 15:47
1457
Antech launches first comprehensive veterinary diagnostics offering in the UK, including a new state-of-the-art reference laboratory
Antech to offer UK veterinary professionals a complete and flexible diagnostics portfolio spanning reference labs, in-house diagnostics, imaging and software WARWICK, England, 7 Nov. 2023 /PRNewswire/ -- Antech, the full-service veterinary diagnostics business that is part of the Science & Diagno...
2023-11-07 15:30
1430
BioRay Announces First-Patient-In for Phase I Clinical Study of BRY812, a Novel LIV-1 Targeting Antibody Drug Conjugate
SHANGHAI, Nov. 7, 2023 /PRNewswire/ -- BioRay Pharmaceutical Co., Ltd. (hereinafter referred to as BioRay) announced that the first patient has been dosed in the Phase I Clinical trial of BRY812, a third-generation antibody-drug conjugate (ADC) targeting LIV-1 for the treatment of advanced malign...
2023-11-07 14:14
1139
87.5% ORR | Abbisko presented two clinical updates of Pimicotinib at the 2023 CTOS Annual Meeting
SHANGHAI, Nov. 6, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter) announced that two major clinical updates of its CSF-1R inhibitor pimicotinib（ABSK021）were presented at the 2023 Connective Tissue Oncology Society Annual Meeting, which is held inIreland from...
2023-11-07 12:31
1186
2023 World Laureates Association Prize winners awarded in Shanghai
SHANGHAI, Nov. 7, 2023 /PRNewswire/ -- The five winners of the 2023 World Laureates Association Prize (WLA Prize) received their awards for their ground-breaking achievements in computer science or mathematics and life science or medicine onNov. 6 at the opening ceremony of the 6th WLA Forum held...
2023-11-07 09:49
491
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 319 media titles]
2024-05-03 06:59
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 295 media titles]
2024-04-30 10:11
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 289 media titles]
2024-05-03 06:25TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 262 media titles]
2024-05-02 01:21
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 253 media titles]
2024-04-30 15:13Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
12314
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
7944
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
2024-04-30 10:11
7544
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
7480
